

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | — | — | — | — | 1 |
| Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
| Drug common name | Rogaratinib |
| INN | rogaratinib |
| Description | Rogaratinib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target fibroblast growth factor receptor 1 and fibroblast growth factor receptor 3. |
| Classification | Small molecule |
| Drug class | tyrosine kinase inhibitors |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | COCc1c(-c2cc3cc(C)cc(OC)c3s2)c2c(N)ncnn2c1CN1CCNC(=O)C1 |
| PDB | — |
| CAS-ID | 1443530-05-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL3963485 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 98BSN6N516 (ChemIDplus, GSRS) |

